The global botulinum toxin (BNT) market is expected to reach a value of USD 7.3 billion by 2025. The constant introduction of innovative products for enhancement of aesthetic appeal supporting minimally invasive aesthetic treatments is the prime factor driving the growth of the market. In addition, the rapid growth of the sector is attributed to the rising demand for minimally invasive or non-invasive procedures. These procedures provide advantages such as small incision, shorter hospital stay, and rapid wound healing, and hence lead to larger acceptance and demand. In addition, the availability of a wide variety of minimally invasive or non-invasive treatment options is pushing the global botulinum toxin market towards growth.
Also,
the successful completion of research projects is expected to expand the
applications of presently approved products. Companies are trying to widen the
application of botulinum toxin in the therapeutic area through various research
activities. For instance, Botox by Allergan received the U.S. FDA approval for
the treatment of strabismus (crossed eyes) and blepharospasm associated with
dystonia in 1989. Furthermore, in 2004, Botox was approved by the U.S. FDA for
hyperidrosis, cervical dystonia, upper limb spasticity, chronic migraine, and
urinary incontinence in 2009, 2010, and 2011 respectively. Hence, these factors
all together will aid in boosting the growth of BNT sales during the forecast
period.
For Full Research Report On Botulinum Toxin Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/botulinum-toxin-market
Further Key
Findings from the Study Suggest:
- The rapid adoption of
minimally invasive treatment is augmenting the growth of neurotoxins
market.
- The botulinum toxin type A
segment accounted for the largest share in 2015 and is also anticipated to
be the fastest-growing segment during the forecast period
- In 2015, North America
dominated the global space with the largest revenue share owing to the
high demand for minimally invasive or non-invasive aesthetic treatments
- Asia Pacific is expected to
emerge as the fastest-growing region during the forecast period, mainly
due to growing social awareness regarding anti-wrinkle procedures in
India, China, and Japan
- Major players competing in
this market include but are not limited to Allergan, Inc.; Ipsen Group;
Merz GmbH and Co. KGaA, Medytox, Inc.; US Worldmed, LLC; Lanzhou Institute
of Biological Products. Co.Ltd. and Revance Therapeutics, Inc.
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/botulinum-toxin-market/request/rs1
Grand View Research has segmented
the botulinum toxin market by type, end use, and region:
Product Type
Outlook (Revenue, USD Million; 2013 - 2025)
- Botulinum Toxin Type A
- Botulinum Toxin Type B
End-use Outlook
(Revenue, USD Million; 2013 - 2025)
- Therapeutic
- Aesthetic
Regional Outlook
(Revenue, USD Million; 2013 - 2025)
- North America
- The U.S.
- Canada
- Europe
- Germany
- The U.K.
- Asia Pacific
- China
- Japan
- Latin America
- Mexico
- Brazil
- MEA
- South Africa
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment